Redirect Notice

Looks like you clickedhttps://www.businesswire.com/news/home/20221012005257/en/Janux-Therapeutics-Announces-First-Patient-Dosed-with-JANX007-in-First-in-Human-Phase-1-Clinical-Trial-in-Patients-with-Prostate-Cancer

If you do not want to visit that page, you can close this browser tab.